Vaxart, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$186M
↑+11.8% +$20Mvs FY2024
Total Liabilities
$98M
↓-8.5% -$9Mvs FY2024
Equity
$88M
↑+49.0% +$29Mvs FY2024
Cash
$64M
↑+23.4% +$12Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $186M | $166M |
| Current Assets | $136M | $68M |
| Cash | $64M | $52M |
| ST Investments | $10M | $26M |
| Receivables | $15M | $6M |
| Inventory | $0 | $0 |
| Other Current | $48M | $0 |
| Non-Current Assets | $50M | $98M |
| PPE | $5M | $9M |
| Goodwill | $5M | $5M |
| Intangibles | $3M | $4M |
| Investments | $0 | $0 |
| Other Non-Current | $37M | $81M |
| Total Liab+Eq | $186M | $166M |
| Current Liab. | $87M | $91M |
| Accounts Payable | $21M | $7M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $65M | $84M |
| Non-Current Liab. | $12M | $17M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $12M | $17M |
| Equity | $88M | $59M |
| Retained Earnings | $460M | $477M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · VXRT · Comparing FY2025 vs FY2024